Medicinal and edible nutritional composition with liver nourishing and protecting effects as well as preparation method and application of medicinal and edible nutritional composition

Through the traditional Chinese medicine nutritional composition with 'medicinal and food homologous', specific plant extracts and amino acids are used to prepare into oral preparations, which solves the shortcomings of liver damage prevention and treatment, significantly reduces the increase of aminotransferase and reduces liver damage. Provide an effective medicinal therapy.

CN118975668APending Publication Date: 2024-11-19TIANJIN TIANJIE DIXIANG BIOTECHNOLOGY DEVELOPMENT CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411213972.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-31
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

Patients with liver disease caused by liver injury lack effective early intervention and preventive measures, which leads to the occurrence of cirrhosis and liver cancer. The prior art has shortcomings in the prevention and treatment of liver injury.

Method used

Using a 'medic and food-homologous' traditional Chinese medicine nutritional composition, including artichoke extract, pueraria root extract, wolfberry extract, citrus cerevisia extract, bitter melon extract, poria cocos extract, Gastrodia elata extract, cinnamon extract , oyster peptides, leucine, isoleucine and rice bran fatty alkanols are extracted, concentrated and dried by water to be prepared into powder or preparations for oral administration, for improvement of liver damage and maintenance of liver health.

Benefits of technology

This composition can effectively reduce the increase of transaminase AST and ALT, reduce liver damage, and play a role in nourishing and protecting the liver, significantly inhibit liver damage caused by CCl4, D-galactose and alcohol, providing an auxiliary treatment for medicinal therapy. Treatment methods.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005020990780000051
    Figure BDA0005020990780000051
  • Figure BDA0005020990780000061
    Figure BDA0005020990780000061
  • Figure BDA0005020990780000071
    Figure BDA0005020990780000071
Patent Text Reader

Abstract

The invention provides a medicinal and edible nutritional composition for nourishing and protecting liver and application of the medicinal and edible nutritional composition in preparation of a nutritional preparation for improving liver injury. The composition is prepared from artichoke extract, radix puerariae extract, fructus lycii extract, hovenia dulcis thunb extract, bitter gourd extract, poria cocos extract, gastrodia elata extract, cinnamon extract, angelica sinensis extract, oyster peptide, leucine, isoleucine, valine and rice bran fatty alkanol, can be used for effectively improving the nutritional state of a patient suffering from liver injury, and has the effects of protecting the liver, improving the immunity and the like. The transaminase effect is reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of medical care, and in particular to a nutritious composition of medicine and food for nourishing and protecting the liver and an application thereof in preparing a nutritious preparation for improving liver damage. Background Art

[0002] The liver is the largest solid organ in the abdominal cavity and the central station for the metabolism of substances and energy in the body. It is estimated that there are more than 500 chemical reactions occurring in the liver. The main functions include: ① secreting bile to help digest food; ② participating in the synthesis, decomposition and transformation of various nutrients, including proteins, lipids, sugars, vitamins, etc., to maintain the normal physiological functions of the human body. ③ It can oxidize, reduce and decompose toxins in the body and engulf bacteria that enter the body. It is the largest detoxification organ in the human body.

[0003] Viral infection, inappropriate medication, excessive intake of food additives, excessive drinking, eating toxic food or radiation damage can all cause liver damage and lead to liver disease. At present, the number of people with liver disease in the world has reached 1.3 billion, which is one of the global public health issues.

[0004] Types of liver diseases can be divided into viral liver diseases and non-viral liver diseases according to the pathogenesis. Viral liver diseases: a group of infectious diseases mainly causing liver damage caused by a variety of different hepatitis viruses. According to etiological diagnosis, there are at least 5 types of hepatitis viruses, namely hepatitis A, B, C, D, and E viruses, which cause viral hepatitis A, B, C, D, and E, respectively. Non-viral liver diseases mainly include alcoholic liver disease, drug or toxic liver disease, etc. Alcoholic liver disease: a liver damage disease caused by long-term heavy drinking (alcoholism). Drug or toxic liver disease: toxic hepatitis is hepatitis or liver lesions caused by chemical poisons (such as phosphorus, arsenic, carbon tetrachloride, etc.), drugs or biological toxins.

[0005] Various factors lead to liver damage. If not treated in time or treated improperly, it may cause liver fibrosis and eventually lead to cirrhosis or liver cancer. Therefore, early intervention, liver care, and prevention of liver damage are the most effective ways to prevent cirrhosis and liver cancer.

[0006] In the prevention and health care of liver diseases, the application of "medicine and food of the same origin" ingredients has a long history. There are a large number of records of medicinal diets (medicine and food of the same origin) in ancient medical books, and many guiding principles for the use of medicinal diets are proposed, and there are also many references to the medicinal diet therapy of liver diseases in traditional Chinese medicine. In "Treatise on Febrile and Miscellaneous Diseases" written by Zhang Zhongjing in the late Eastern Han Dynasty, bitter wine soup uses rice vinegar and eggs to soothe and protect the liver; Sun Simiao's "Prescriptions for Emergencies" in the Tang Dynasty has a special discussion on "food therapy" in the 26th volume; his disciple Meng Xian wrote "Food Therapy Materia Medica". Li Shizhen's "Compendium of Materia Medica" in the Ming Dynasty includes a large number of food-based medicines that prolong life.

[0007] Some international liver disease and nutrition-related societies have successively issued nutritional guidelines for liver disease. The European Society for Parenteral Nutrition issued the "Guidelines for Enteral Nutrition in Liver Disease" in 2006, the "Guidelines for Parenteral Nutrition in Liver Disease" in 2009, and the "Clinical Nutrition Guidelines for Liver Disease" in 2019. In 2018, the European Association for the Study of the Liver issued the "Clinical Practice Guidelines for Nutrition in Chronic Liver Disease". Nutritional intervention plays an increasingly important role in the prevention and treatment of liver disease.

[0008] Based on the above theory, developing a "medicine and food" nutritional composition is of great significance for nutritional regulation and auxiliary treatment of patients with liver damage. Summary of the invention

[0009] The purpose of the present invention is to apply the theory of liver nourishing and protecting in traditional Chinese medicine and the theory of dietary nutrition in traditional Chinese medicine to provide a "medicine and food of the same origin" traditional Chinese medicine nutritional product to regulate the nutrition of patients with liver damage and maintain the health of patients.

[0010] The purpose of the present invention is achieved through the following technical methods:

[0011] On the one hand, the present invention provides a medicinal and edible nutritional composition for nourishing and protecting the liver, wherein the composition is prepared from the following raw materials: artichoke extract, kudzu root extract, wolfberry extract, Hovenia dulcis extract, bitter melon extract, Poria cocos extract, Gastrodia elata extract, cinnamon extract, angelica extract, oyster peptide, leucine, isoleucine, valine, and rice bran fatty alkyl alcohol.

[0012] Preferably, the weight ratio of the raw materials is: 10-45 parts of artichoke extract, 10-45 parts of kudzu root extract, 5-30 parts of wolfberry extract, 2-20 parts of Hovenia dulcis extract, 1-15 parts of momordica charantia extract, 1-15 parts of Poria cocos extract, 1-15 parts of Gastrodia elata extract, 1-15 parts of cinnamon extract, 1-15 parts of angelica extract, 1-10 parts of oyster peptide, 1-10 parts of leucine, 1-10 parts of isoleucine, 1-10 parts of valine, and 1-10 parts of rice bran fatty alkanol.

[0013] Further preferably, the weight ratio of the raw materials is: 15-30 parts of artichoke extract, 15-30 parts of kudzu root extract, 8-20 parts of wolfberry extract, 5-15 parts of Hovenia dulcis extract, 2-10 parts of momordica charantia extract, 2-10 parts of Poria cocos extract, 2-10 parts of Gastrodia elata extract, 2-10 parts of cinnamon extract, 2-10 parts of angelica extract, 1-5 parts of oyster peptide, 1-5 parts of leucine, 1-5 parts of isoleucine, 1-5 parts of valine, and 1-5 parts of rice bran fatty alcohol.

[0014] More preferably, the weight ratio of the raw materials is: 25 parts of artichoke extract, 20 parts of kudzu root extract, 9 parts of wolfberry extract, 6 parts of Hovenia dulcis extract, 3 parts of bitter melon extract, 2 parts of Poria extract, 3 parts of Gastrodia elata extract, 3 parts of cinnamon extract, 3 parts of Angelica sinensis extract, 2 parts of oyster peptide, 1.5 parts of leucine, 0.75 parts of isoleucine, 0.75 parts of valine, and 1 part of rice bran fatty alkyl alcohol.

[0015] In addition, the nutritional composition is characterized in that the oral preparation is a tablet, powder, capsule, pill, emulsion, oral liquid or syrup; preferably a tablet.

[0016] On the other hand, the present invention also provides a method for preparing the above composition, the preparation method comprising:

[0017] (1) Artichoke, kudzu root, wolfberry, Hovenia dulcis, bitter melon, Poria, Gastrodia elata, cinnamon bark, and Chinese angelica are extracted with water respectively, the precipitate is filtered out, the extract is concentrated to obtain an extract, and the extract is dried and crushed to obtain a powder;

[0018] (2) The powder obtained in step (1) is stirred and mixed with oyster peptide, leucine, isoleucine, valine and rice bran fatty alcohol until uniform.

[0019] In another aspect, the present invention provides use of the above-mentioned composition in preparing a nutritional preparation for nourishing and protecting the liver and improving liver damage.

[0020] The composition of the present invention can effectively improve weight loss and elevated transaminase caused by liver damage, and plays a role in nourishing and protecting the liver. DETAILED DESCRIPTION

[0021] The present invention is further described in detail below in conjunction with specific embodiments. The given examples are only for illustrating the present invention, but not for limiting the scope of the present invention.

[0022] Example 1: Preparation of raw material powder of nutritional composition

[0023] (1) 500 g each of artichoke, kudzu root, wolfberry, Hovenia dulcis, bitter melon, and Poria cocos, 100 g each of Gastrodia elata, cinnamon bark, and Chinese angelica were decocted in water for 3 times, each time using 5000 ml of water for 1.5 hours, and the water extract was filtered;

[0024] (2) respectively concentrating the extracts under reduced pressure to 500 g, with a density of 1.08;

[0025] (3) drying the concentrated liquids under reduced pressure at a drying temperature of 70° C., crushing them, and sieving them through an 80-mesh sieve to obtain dry powders of several raw materials;

[0026] Example 2: Preparation of nutritional composition (ratio 1) tablets

[0027] 45 g of artichoke extract, 45 g of kudzu root extract, 30 g of wolfberry extract, 20 g of Hovenia dulcis extract, 5 g of bitter melon extract, 5 g of Poria cocos extract, 5 g of Gastrodia elata extract, 5 g of cinnamon extract, and 5 g of Angelica sinensis extract prepared according to the method of Example 1 were weighed separately, and mixed with 1 g of oyster peptide, 1 g of leucine, 1 g of isoleucine, 1 g of valine, 1 g of rice bran fatty alkyl alcohol, 35.5 g of microcrystalline cellulose, and 7 g of magnesium stearate, granulated, and tableted.

[0028] Example 3: Preparation of nutritional composition (ratio 2) tablets

[0029] 10 g of artichoke extract, 10 g of kudzu root extract, 5 g of wolfberry extract, 2 g of Hovenia dulcis extract, 15 g of bitter melon extract, 15 g of Poria extract, 15 g of Gastrodia elata extract, 15 g of cinnamon extract, and 15 g of Angelica sinensis extract prepared according to the method of Example 1 were weighed separately, and mixed with 5 g of oyster peptide, 10 g of leucine, 5 g of isoleucine, 5 g of valine, 5 g of rice bran fatty alkyl alcohol, 28 g of microcrystalline cellulose, and 5 g of magnesium stearate, granulated, and tableted.

[0030] Example 4: Preparation of nutritional composition (ratio 3) tablets

[0031] 25 g of artichoke extract, 20 g of kudzu root extract, 9 g of wolfberry extract, 6 g of Hovenia dulcis extract, 3 g of bitter melon extract, 3 g of Poria extract, 3 g of Gastrodia elata extract, 3 g of cinnamon extract, and 3 g of Angelica sinensis extract prepared according to the method of Example 1 were weighed separately, and mixed with 2 g of oyster peptide, 1.5 g of leucine, 0.75 g of isoleucine, 0.75 g of valine, 1 g of rice bran fatty alkyl alcohol, 16.25 g of microcrystalline cellulose, and 4 g of magnesium stearate, granulated, and tableted.

[0032] Example 5: Comparative study of different compositions

[0033] 1. Experimental Materials

[0034] 1.1. Nutritional combination group

[0035] Composition 1: Weigh 12.5g of artichoke extract, 10g of kudzu root extract, 4.5g of wolfberry extract, 3g of Hovenia dulcis extract, 1.5g of bitter melon extract, 1.5g of Poria extract, 1.5g of Gastrodia elata extract, 1.5g of cinnamon extract, and 1.5g of Angelica sinensis extract, and mix with 1g of oyster peptide, 0.75g of leucine, 0.375g of isoleucine, 0.375g of valine, and 0.5g of rice bran fatty alkyl alcohol. Prepare a 24mg / mL solution with distilled water before use for oral administration.

[0036] Composition 2: Weigh 12.5 g of artichoke extract, 10 g of kudzu root extract, 4.5 g of wolfberry extract, and 3 g of Hovenia dulcis extract, mix well, and prepare into a 24 mg / mL solution with distilled water before use for oral administration.

[0037] Composition 3: Weigh 3 g of bitter melon extract, 3 g of Poria cocos extract, 3 g of Gastrodia elata extract, 3 g of cinnamon bark extract, and 3 g of Angelica sinensis extract, mix well, and prepare into a 24 mg / mL solution with distilled water before use for oral administration.

[0038] Composition 4: Weigh 2g of oyster peptide, 1.5g of leucine, 0.75g of isoleucine, 0.75g of valine, and 1g of rice bran fatty alkyl alcohol, mix well, and prepare into a 24mg / mL solution with distilled water before use for oral administration.

[0039] 1.2. Reagents

[0040] Carbon tetrachloride: Product of Tianjin Reagent Factory. Prepare 0.1% oil solution with injection oil before use.

[0041] Kits: Alanine aminotransferase kit and aspartate aminotransferase kit, both from Wuhan Elerite Biotechnology Co., Ltd.

[0042] 1.3 Animals

[0043] ICR mice, male, were provided by Sibeifu (Beijing) Biotechnology Co., Ltd., animal certificate number SCXK (Beijing) 2024-0001.

[0044] 1.4 Instruments

[0045] High-speed refrigerated centrifuge (Sorvall ST 8R), Thermo Fisher Scientific (China) Co., Ltd.

[0046] Multifunctional microplate reader (M5), Berthold, Germany.

[0047] 2. Experimental Methods

[0048] 48 ICR mice, weighing 20-25g, were randomly divided into 6 groups according to body weight, 8 mice in each group, including normal control group, model control group, composition group 1, composition group 2, composition group 3, and composition group 4. Composition groups 1-4 were intragastrically administered with the nutritional composition, with a volume of 10ml / kg body weight, and the normal control group and model control group were administered with the same volume of distilled water, once a day for 3 consecutive days. One hour after the nutritional composition was administered on the third day, all mice except the normal control group were intraperitoneally injected with 0.1% CCl 4The subjects were given oil solution (10 ml / kg body weight). The normal control group was given the same volume of injection oil. Blood was collected 24 hours later. The subjects were fasted for 12 hours before blood collection. Serum was collected by centrifugation at 3000 rpm for 10 min. ALT and AST were measured using kits, and the results were statistically analyzed using one-way analysis of variance.

[0049] 3. Experimental results

[0050] The results showed that the whole formula combination group 1 could significantly inhibit the intraperitoneal injection of CCl 4 The effect of the combination was better than that of the combination 2-4 groups, as shown in Table 1.

[0051] Table 1 Nutrient composition for CCl 4 Effects of acute liver injury in mice

[0052]

[0053] Note: (1) Compared with the normal control group, ##P<0.01. (2) Compared with the model group, **P<0.01.

[0054] Example 6: Protective effect on liver damage caused by D-galactose

[0055] 1. Experimental Materials

[0056] 1.1. Nutritional combination group

[0057] Nutritional combination group: 12.5g of artichoke extract, 10g of kudzu root extract, 4.5g of wolfberry extract, 3g of Hovenia dulcis extract, 1.5g of bitter melon extract, 1.5g of Poria extract, 1.5g of Gastrodia elata extract, 1.5g of cinnamon extract, 1.5g of Angelica sinensis extract, 1g of oyster peptide, 0.75g of leucine, 0.375g of isoleucine, 0.375g of valine, and 0.5g of rice bran fatty alkyl alcohol were weighed and mixed. Three solutions of 6, 12, and 24mg / mL were prepared with distilled water.

[0058] 1.2. Reagents

[0059] D-galactose: a product of Bio-Technology Co., Ltd., prepared with physiological saline before use and adjusted to pH 7.0 with 1N NaOH.

[0060] Kit: Kit: Alanine aminotransferase kit, aspartate aminotransferase kit, both are from Wuhan Elerite Biotechnology Co., Ltd.

[0061] 1.3. Instruments

[0062] High-speed refrigerated centrifuge (Sorvall ST 8R), Thermo Fisher Scientific (China) Co., Ltd.

[0063] Multifunctional microplate reader (M5), Berthold, Germany.

[0064] 1.4. Animals

[0065] 40 female SD rats, weighing 200-300 g, were provided by Sibeifu (Beijing) Biotechnology Co., Ltd., with animal certificate number SCXK (Beijing) 2024-0001.

[0066] 2. Experimental Methods

[0067] 40 SD rats, weighing 200-300g, female, were randomly divided into 5 groups according to body weight, 8 rats in each group: normal control group, model control group, and 3 low, medium and high dose groups of the nutritional composition. The three dose groups of the nutritional composition were gavaged with 60, 120, and 240 mg / kg of the nutritional composition, with a capacity of 10 ml / kg body weight; the normal control group and the model control group were given the same volume of distilled water, once a day, for 3 consecutive days. One hour after administration on the third day, all rats except the normal control group were intraperitoneally injected with D-galactose saline solution, with a dose of 500 mg / kg, and the normal control group was injected with the same volume of saline. Blood was collected 24 hours later, and fasting was performed for 16 hours before blood collection. Blood was collected to separate serum, and AST and ALT were measured with a kit. The results were statistically processed using one-way analysis of variance.

[0068] 3. Experimental results

[0069] The results showed that the nutritional composition group could significantly inhibit the increase of serum aminotransferase AST and ALT levels caused by intraperitoneal injection of D-galactosamine in rats, and the effect was dose-dependent. The high-dose 240 mg / kg nutritional composition had the best effect in reducing AST and ALT, as shown in Table 2.

[0070] Table 2 Effect of nutritional composition on acute liver injury induced by D-galactose in rats

[0071]

[0072] Note: (1) Compared with the normal control group, ##P<0.01. (2) Compared with the model group, *P<0.05, **P<0.01.

[0073] Example 7: Protective effect on alcohol-induced liver damage

[0074] 1. Experimental Materials

[0075] 1.1. Nutritional combination group

[0076] Nutritional combination group: 12.5g of artichoke extract, 10g of kudzu root extract, 4.5g of wolfberry extract, 3g of Hovenia dulcis extract, 1.5g of bitter melon extract, 1.5g of Poria extract, 1.5g of Gastrodia elata extract, 1.5g of cinnamon extract, 1.5g of Angelica sinensis extract, 1g of oyster peptide, 0.75g of leucine, 0.375g of isoleucine, 0.375g of valine, and 0.5g of rice bran fatty alkyl alcohol were weighed and mixed. Three solutions of 12, 24, and 48mg / mL were prepared with distilled water.

[0077] 1.2. Reagents

[0078] Ethanol: A product of Tianjin Hengxing Chemical Reagent Manufacturing Co., Ltd., prepared with distilled water to 60% alcohol before use.

[0079] Kit: Kit: Alanine aminotransferase kit, aspartate aminotransferase kit, both are from Wuhan Elerite Biotechnology Co., Ltd.

[0080] 1.3. Instruments

[0081] High-speed refrigerated centrifuge (Sorvall ST 8R), Thermo Fisher Scientific (China) Co., Ltd.

[0082] Multifunctional microplate reader (M5), Berthold, Germany.

[0083] 1.4. Animals

[0084] ICR mice, male, were provided by Sibeifu (Beijing) Biotechnology Co., Ltd., animal certificate number SCXK (Beijing) 2024-0001.

[0085] 2. Experimental Methods

[0086] 40 ICR mice, weighing 22-26g, male, were randomly divided into 5 groups according to body weight, 8 mice in each group: normal control group, model control group, and 3 low, medium and high dose groups of the nutritional composition. The three dose groups of the nutritional composition were gavaged with 120, 240, and 480 mg / kg of the nutritional composition, with a capacity of 10 ml / kg body weight; the normal control group and the model control group were given the same volume of distilled water, once a day for 7 consecutive days. Except for the normal control group, all mice were gavaged with 60% ethanol 10 minutes after gavage with nutrient solution or distilled water, with a capacity of 10 ml / kg body weight. Blood was collected on the 7th day, and fasting was performed for 16 hours before blood collection. Blood was collected to separate serum, and AST and ALT were measured with a kit. The results were statistically processed using one-way analysis of variance.

[0087] 3. Experimental results

[0088] The results showed that the nutritional composition group could significantly inhibit the increase of serum aminotransferase AST and ALT levels caused by alcohol administration in mice, and the effect was dose-dependent. The high-dose 240 mg / kg nutritional composition had the best effect in reducing AST and ALT, as shown in Table 3.

[0089] Table 3 Effects of nutritional composition on alcohol-induced acute liver injury in rats

[0090]

[0091] Note: (1) Compared with the normal control group, ##P<0.01. (2) Compared with the model group, *P<0.05, **P<0.01.

[0092] Conclusion: The nutritional composition can reduce CCl 4 , D-galactose, and alcohol-induced increases in serum transaminase AST and ALT, playing a role in nourishing and protecting the liver and reducing liver damage. The whole formula nutritional composition is superior to the decomposed formula of the nutritional composition.

Claims

1. A medicinal and edible nutritional composition with the effects of nourishing and protecting the liver, the composition being prepared from the following raw materials: artichoke extract, kudzu root extract, wolfberry extract, Hovenia dulcis extract, bitter melon extract, Poria cocos extract, Gastrodia elata extract, cinnamon extract, angelica extract, oyster peptide, leucine, isoleucine, valine, and rice bran fatty alkyl alcohol.

2. The nutritional composition according to claim 1, characterized in that The weight ratio of the raw materials is: 10-45 parts of artichoke extract, 10-45 parts of kudzu root extract, 5-30 parts of wolfberry extract, 2-20 parts of Hovenia dulcis extract, 1-15 parts of momordica charantia extract, 1-15 parts of Poria cocos extract, 1-15 parts of Gastrodia elata extract, 1-15 parts of cinnamon extract, 1-15 parts of angelica extract, 1-10 parts of oyster peptide, 1-10 parts of leucine, 1-10 parts of isoleucine, 1-10 parts of valine, and 1-10 parts of rice bran fatty alkanol.

3. The nutritional composition according to claims 1-2, characterized in that The weight ratio of the raw materials is preferably: 15-30 parts of artichoke extract, 15-30 parts of kudzu root extract, 8-20 parts of wolfberry extract, 5-15 parts of Hovenia dulcis extract, 2-10 parts of momordica charantia extract, 2-10 parts of Poria cocos extract, 2-10 parts of Gastrodia elata extract, 2-10 parts of cinnamon extract, 2-10 parts of angelica extract, 1-5 parts of oyster peptide, 1-5 parts of leucine, 1-5 parts of isoleucine, 1-5 parts of valine, and 1-5 parts of rice bran fatty alkanol.

4. The nutritional composition according to claims 1-3, characterized in that The weight ratio of the raw materials is more preferably: 25 parts of artichoke extract, 20 parts of kudzu root extract, 9 parts of wolfberry extract, 6 parts of Hovenia dulcis extract, 3 parts of bitter melon extract, 2 parts of Poria extract, 3 parts of Gastrodia elata extract, 3 parts of cinnamon extract, 3 parts of Angelica sinensis extract, 2 parts of oyster peptide, 1.5 parts of leucine, 0.75 parts of isoleucine, 0.75 parts of valine, and 1 part of rice bran fatty alkyl alcohol.

5. The nutritional composition according to any one of claims 1 to 4, characterized in that The drug can be prepared into any pharmaceutically acceptable oral dosage form.

6. The nutritional composition according to claim 5, characterized in that The oral preparation is a tablet, powder, capsule, pill, emulsion, oral liquid or syrup; preferably a tablet.

7. A method for preparing the composition according to any one of claims 1 to 4, comprising: (1) Extract artichoke, kudzu root, wolfberry, Hovenia dulcis, bitter melon, Poria, Gastrodia elata, cinnamon bark, and Chinese angelica with water, filter out the precipitate, concentrate into extract, dry, grind and make into powder; (2) The powder obtained in step (1) is stirred and mixed with oyster peptide, leucine, isoleucine, valine and rice bran fatty alcohol until uniform.

8. Use of the nutritional composition according to any one of claims 1 to 4 in the preparation of a nutritional preparation for nourishing and protecting the liver and improving liver damage.